VaramirStart free · no cardSign in
ATOS as of Nov 3 · 18:51 ET
ATOSNasdaqPharmaceutical Preparations

Atossa Therapeutics, Inc. · Brief

Next report

8 days

Nov 11 · before openest.Q3 FY26
Earnings

Expected move

No implied move.

Implied vs realized

1 reportHistory
—≥ implied
Q2 FY26±27.7%▼−2.48%×0.09
quarterimplied−30%0+30%realized×
Q2 FY26±27.7%▼−2.48%×0.09
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 11 report · est.

—

Linked exposure

ATOS report session

No linked exposure.

Latest changes

30 daysAll changes
Oct 28impliedImplied move: ±35.9% into Nov 11 earnings (Oct 28 close).Source
Oct 98-KMaterial agreement: Stapled Contingent Value Rights Agreement with VStock Transfer, LLC.Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.